ReviewAustralian prescriber2020
Deprescribing in older people.
Review in Australian prescriber, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Assessing the maintenance of hospital discharge prescriptions in the older population: a systematic literature review.BMC geriatrics · 2026Pooled it
- [PAPPS update on older people 2024].Atencion primaria · 2024Guideline
- Feasibility & Efficacy of Deprescribing rounds in a Singapore rehabilitative hospital- a randomised controlled trial.BMC geriatrics · 2021Trial
- Concurrent use of medicines with similar adverse drug reaction profiles in older adults: identifying potential deprescribing opportunities using population-level dispensing data.International journal of clinical pharmacy · 2026Article
- Hospital readmissions related to adverse drug withdrawal events in older adults: a pilot study.International journal of clinical pharmacy · 2026Article
- Hyperpolypharmacy in patients with chronic kidney disease and its impact on clinical outcomes.Scientific reports · 2026Article
- Myofascial pain in older adults: a geroscience-informed framework integrating precision geriatrics and digital therapeutics.Frontiers in aging neuroscience · 2026Review
- Development and validation of a deprescribing tool relevant to older persons in India using modified Delphi consensus technique.BMC geriatrics · 2025Article
- Association Between Prehip Fracture Antidepressant Use and Posthip Fracture Length of Hospital Stay in Medicare Beneficiaries and Assessing Sex Differences.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2025Article
- Analysis of longitudinal patterns and predictors of medicine use in residential aged care using group-based trajectory modelling: The MEDTRAC-Polypharmacy longitudinal cohort study.British journal of clinical pharmacology · 2024Article
- Potentially Inappropriate Medication: A Pilot Study in Institutionalized Older Adults.Healthcare (Basel, Switzerland) · 2024Article
- Deprescribing antihypertensive drugs in frail older adults.Australian prescriber · 2024Review
- A need to integrate pharmacological management for multimorbidity into dementia guidelines in Australia.Frontiers in public health · 2024Review
- Gabapentinoids: a therapeutic review.Australian prescriber · 2023Review
- Perioperative Anxiety and Depression in Older Adults: Epidemiology and Treatment.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2023Review
- A stewardship program to facilitate anticholinergic and sedative medication deprescribing using the drug burden index in electronic medical records.British journal of clinical pharmacology · 2023Article
- Optimizing treatment for older adults with depression.Therapeutic advances in psychopharmacology · 2023Review
- [PAPPS update on older people 2022].Atencion primaria · 2022Article
- The anticholinergic burden: from research to practice.Australian prescriber · 2022Review
- Medicines use before and after comprehensive medicines review among residents of long-term care facilities: a retrospective cohort study.BMC geriatrics · 2022Article
Corrections and comments
- Commented on by
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Deprescribing is the process of discontinuing drugs that are either potentially harmful or no longer required. It can be achieved in older people and may be associated with improved health outcomes without long-term adverse effects. The risk of drug withdrawal effects can often be mitigated by carefully monitoring and gradually tapering the dose. Deprescribing should ideally be a shared decision-making process between the patient and the prescriber.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.